Related Experiment Videos
Intralesional interferon alpha-2b therapy for Buschke-Loewenstein tumour
D Tsambaos1, A Monastirli, N Kapranos
1Department of Dermatology, University of Patras, Greece.
Acta Dermato-Venereologica
|November 1, 1994
Abstract:
A patient with a Buschke-Loewenstein tumour associated with human papillomavirus type 6/11 is reported. He was intralesionally treated with human recombinant alpha-2b interferon (9 x 10(6) IU/day) three times weekly. The tumour completely disappeared within 5 months of continuous treatment which was well tolerated. Sixteen months after completion of therapy the patient remains well and free of disease.